124 related articles for article (PubMed ID: 29618015)
1. High Fear of Disease Occurrence Is Associated With Low Quality of Life in Patients With Multiple Endocrine Neoplasia Type 1: Results From the Dutch MEN1 Study Group.
van Leeuwaarde RS; Pieterman CRC; Bleiker EMA; Dekkers OM; van der Horst-Schrivers AN; Hermus AR; de Herder WW; Drent ML; Bisschop PH; Havekes B; Vriens MR; Valk GD
J Clin Endocrinol Metab; 2018 Jun; 103(6):2354-2361. PubMed ID: 29618015
[TBL] [Abstract][Full Text] [Related]
2. Health-Related Quality of Life in Patients with Multiple Endocrine Neoplasia Type 1.
van Leeuwaarde RS; Pieterman CRC; May AM; Dekkers OM; van der Horst-Schrivers AN; Hermus AR; de Herder WW; Drent ML; Bisschop PH; Havekes B; Vriens MR; Valk GD
Neuroendocrinology; 2021; 111(3):288-296. PubMed ID: 32365349
[TBL] [Abstract][Full Text] [Related]
3. Impact of Delay in Diagnosis in Outcomes in MEN1: Results From the Dutch MEN1 Study Group.
van Leeuwaarde RS; van Nesselrooij BP; Hermus AR; Dekkers OM; de Herder WW; van der Horst-Schrivers AN; Drent ML; Bisschop PH; Havekes B; Vriens MR; de Laat JM; Pieterman CR; Valk GD
J Clin Endocrinol Metab; 2016 Mar; 101(3):1159-65. PubMed ID: 26751192
[TBL] [Abstract][Full Text] [Related]
4. Clues For Genetic Anticipation In Multiple Endocrine Neoplasia Type 1.
van den Broek MFM; van Nesselrooij BPM; Pieterman CRC; Verrijn Stuart AA; van de Ven AC; de Herder WW; Dekkers OM; Drent ML; Havekes B; Kerstens MN; Bisschop PH; Valk GD
J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32396602
[TBL] [Abstract][Full Text] [Related]
5. MEN1-Dependent Breast Cancer: Indication for Early Screening? Results From the Dutch MEN1 Study Group.
van Leeuwaarde RS; Dreijerink KM; Ausems MG; Beijers HJ; Dekkers OM; de Herder WW; van der Horst-Schrivers AN; Drent ML; Bisschop PH; Havekes B; Peeters PHM; Pijnappel RM; Vriens MR; Valk GD
J Clin Endocrinol Metab; 2017 Jun; 102(6):2083-2090. PubMed ID: 28323962
[TBL] [Abstract][Full Text] [Related]
6. Disease and treatment factors associated with lower quality of life scores in adults with multiple endocrine neoplasia type I.
Goswami S; Peipert BJ; Helenowski I; Yount SE; Sturgeon C
Surgery; 2017 Dec; 162(6):1270-1277. PubMed ID: 28919050
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Natural Course of Pituitary Tumors in Patients With MEN1: Results From the DutchMEN1 Study Group (DMSG).
de Laat JM; Dekkers OM; Pieterman CR; Kluijfhout WP; Hermus AR; Pereira AM; van der Horst-Schrivers AN; Drent ML; Bisschop PH; Havekes B; de Herder WW; Valk GD
J Clin Endocrinol Metab; 2015 Sep; 100(9):3288-96. PubMed ID: 26126205
[TBL] [Abstract][Full Text] [Related]
8. Predicting the risk of multiple endocrine neoplasia type 1 for patients with commonly occurring endocrine tumors.
de Laat JM; Tham E; Pieterman CR; Vriens MR; Dorresteijn JA; Bots ML; Nordenskjöld M; van der Luijt RB; Valk GD
Eur J Endocrinol; 2012 Aug; 167(2):181-7. PubMed ID: 22581216
[TBL] [Abstract][Full Text] [Related]
9. No Association of Blood Type O With Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1.
Nell S; van Leeuwaarde RS; Pieterman CR; de Laat JM; Hermus AR; Dekkers OM; de Herder WW; van der Horst-Schrivers AN; Drent ML; Bisschop PH; Havekes B; Borel Rinkes IH; Vriens MR; Valk GD
J Clin Endocrinol Metab; 2015 Oct; 100(10):3850-5. PubMed ID: 26247473
[TBL] [Abstract][Full Text] [Related]
10. Traits of Patients With Pituitary Tumors in Multiple Endocrine Neoplasia Type 1 and Comparing Different Mutation Status.
Lin KY; Kuo YT; Cheng MF; Chen PL; Wang HP; Cheng TY; Chang CH; Kao HF; Yang SH; Li HY; Lin CH; Chou YT; Chung AK; Wu WC; Lu JY; Wang CY; Hsih WH; Wen CY; Yang WS; Shih SR
J Clin Endocrinol Metab; 2023 Nov; 108(12):e1532-e1541. PubMed ID: 37390813
[TBL] [Abstract][Full Text] [Related]
11. Multiple endocrine neoplasia type 1 syndrome: single centre experience from western India.
Goroshi M; Bandgar T; Lila AR; Jadhav SS; Khare S; Shrikhande SV; Uchino S; Dalvi AN; Shah NS
Fam Cancer; 2016 Oct; 15(4):617-24. PubMed ID: 26905068
[TBL] [Abstract][Full Text] [Related]
12. Thoracic and duodenopancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: natural history and function of menin in tumorigenesis.
Pieterman CR; Conemans EB; Dreijerink KM; de Laat JM; Timmers HT; Vriens MR; Valk GD
Endocr Relat Cancer; 2014 Jun; 21(3):R121-42. PubMed ID: 24389729
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and treatment of multiple endocrine neoplasia type 1 (MEN1).
Gaztambide S; Vazquez F; Castaño L
Minerva Endocrinol; 2013 Mar; 38(1):17-28. PubMed ID: 23435440
[TBL] [Abstract][Full Text] [Related]
14. Quality of life in patients with multiple endocrine neoplasia type 1 (MEN 1).
Berglund G; Lidén A; Hansson MG; Oberg K; Sjöden PO; Nordin K
Fam Cancer; 2003; 2(1):27-33. PubMed ID: 14574164
[TBL] [Abstract][Full Text] [Related]
15. Expression of p27
Conemans EB; Raicu-Ionita GM; Pieterman CRC; Dreijerink KMA; Dekkers OM; Hermus AR; de Herder WW; Drent ML; van der Horst-Schrivers ANA; Havekes B; Bisschop PH; Offerhaus GJ; Borel Rinkes IHM; Valk GD; Timmers HTM; Vriens MR
J Endocrinol Invest; 2018 Jun; 41(6):655-661. PubMed ID: 29134609
[TBL] [Abstract][Full Text] [Related]
16. [Multiple Endocrine Neoplasia I (Wermers Syndrome), Forms of Clinical Manifestation, 5 Case Studies].
Drbalová K; Herdová K; Krejčí P; Nývltová M; Solař S; Vedralová L; Záruba P; Netuka D; Bavor P
Vnitr Lek; 2016; 62(9 Suppl 3):140-149. PubMed ID: 27734708
[TBL] [Abstract][Full Text] [Related]
17. Quality of life in multiple endocrine neoplasia type 2A compared with normative and disease populations.
Mongelli MN; Peipert BJ; Goswami S; Helenowski I; Yount SE; Sturgeon C
Surgery; 2018 Sep; 164(3):546-552. PubMed ID: 29903510
[TBL] [Abstract][Full Text] [Related]
18. Quality of life in Italian patients with Multiple endocrine neoplasia type 1 (MEN 1): results of an extensive survey.
Giusti F; Cioppi F; Fossi C; Marini F; Masi L; Tonelli F; Brandi ML
Orphanet J Rare Dis; 2021 Jan; 16(1):16. PubMed ID: 33407684
[TBL] [Abstract][Full Text] [Related]
19. Multiple endocrine neoplasia type 1 (MEN1): its manifestations and effect of genetic screening on clinical outcome.
Pieterman CR; Schreinemakers JM; Koppeschaar HP; Vriens MR; Rinkes IH; Zonnenberg BA; van der Luijt RB; Valk GD
Clin Endocrinol (Oxf); 2009 Apr; 70(4):575-81. PubMed ID: 18616711
[TBL] [Abstract][Full Text] [Related]
20. Financial burden is associated with worse health-related quality of life in adults with multiple endocrine neoplasia type 1.
Peipert BJ; Goswami S; Helenowski I; Yount SE; Sturgeon C
Surgery; 2017 Dec; 162(6):1278-1285. PubMed ID: 28923697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]